0001209191-23-052206.txt : 20231005 0001209191-23-052206.hdr.sgml : 20231005 20231005163409 ACCESSION NUMBER: 0001209191-23-052206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231004 FILED AS OF DATE: 20231005 DATE AS OF CHANGE: 20231005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luthringer Remy CENTRAL INDEX KEY: 0001610384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36517 FILM NUMBER: 231311791 MAIL ADDRESS: STREET 1: C/O MINERVA NEUROSCIENCES, INC. STREET 2: 1601 TRAPELO ROAD, SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Minerva Neurosciences, Inc. CENTRAL INDEX KEY: 0001598646 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260784194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-600-7373 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-04 0 0001598646 Minerva Neurosciences, Inc. NERV 0001610384 Luthringer Remy C/O MINERVA NEUROSCIENCES, INC. 1500 DISTRICT AVENUE BURLINGTON MA 01803 1 1 0 0 CEO 0 Employee Stock Option (right to buy) 6.41 2023-10-04 4 A 0 100450 0.00 A 2033-10-03 Common Stock 100450 100450 D The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter. /s/ Ryan Sansom, Attorney-in-Fact 2023-10-05